.png)
.png)
Acting Director, Office of Compliance and Biologics Quality, CBER
U.S. FDA
Melissa Mendoza is the Acting Director of the Office of Compliance and Biologics Quality (OCBQ) in the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration. OCBQ is responsible for ensuring the quality of products regulated by CBER over their entire lifecycle, from pre-market review and inspection to post-market review, surveillance, inspection, outreach, and compliance. Before joining CBER, Melissa served as an Associate Chief Counsel for Enforcement in FDA’s Office of the Chief Counsel.
Tuesday, September 28, 2021
09:45 – 10:02 EDT
Tuesday, September 28, 2021
10:57 – 11:15 EDT